Dopamine Hci Injection, Solution, Concentrate
Product Images NDC 51662-1291

7 FDA label images from Hf Acquisition Co Llc, Dba Healthfirst · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Dopamine Hci (NDC 51662-1291). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Vial Label (1007700 0409 5820 01 Dopamine Vial)

Vial Label (1007700 0409 5820 01 Dopamine Vial)
Label for DOPamine HCl Injection, USP 200 mg (40 mg/mL) single-dose 5 mL vial. The label states the product is for intravenous use only and must be diluted. It lists the manufacturer as HOSPIRA, INC., located in Lake Forest, IL 60045 USA, with NDC 0409-5820-01. The label includes information on additional inactive ingredients such as sodium metabisulfite, citric acid, sodium citrate, and sodium added as buffer.*
FDA Label Image

Structure (Desc Structure)

Structure (Desc Structure)
Chemical structure diagram of dopamine hydrochloride, showing a benzene ring with two hydroxyl groups and an ethylamine side chain bound to hydrochloride.*
FDA Label Image

Dosage 1 (Dosage And Admin)

Dosage 1 (Dosage And Admin)
Table showing concentrations of dopamine hydrochloride injection solutions at 40 mg/mL and 80 mg/mL strengths, with associated dopamine microgram per milliliter (mcg/mL) levels for 250 mL, 500 mL, and 1000 mL intravenous solution bottles, and volumes of dopamine hydrochloride injection in milliliters (5 mL, 10 mL).*
FDA Label Image
FDA Label Image

How Supplied 1 (How Supplied)

How Supplied 1 (How Supplied)
A data table showing units of sale and concentration strengths for dopamine HCl injection solution concentrate. The table lists two NDCs: 0409-5820-01 with 200 mg/5 mL (40 mg/mL), and 0409-9104-20 with 400 mg/10 mL (40 mg/mL). Both come 25 in a carton.*
FDA Label Image

Serialized Label (Serialized 51662 1291 1 Dopamine 5ml Vial)

Serialized Label (Serialized 51662 1291 1 Dopamine 5ml Vial)
DOPAMINE HCl Injection, Solution, Concentrate 200 mg (40 mg/mL) in a 5 mL single-dose vial with a green cap. The vial label states it is distributed by HF Acquisition Co LLC, DBA HealthFirst, Mukilteo, WA. The product is for intravenous use and prescription only.*
FDA Label Image

Precautions 1 (Untitled)

Precautions 1 (Untitled)
A drug information text panel titled 'IMPORTANT' focusing on the antidote for peripheral ischemia. It instructs on using phentolamine mesylate solution to treat ischemic areas caused by extravasation, including dosage guidance, administration method, and timing for effective treatment to prevent tissue necrosis.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.